REPORT ID 6554

EMEA (Europe, Middle East and Africa) Liraglutide Market Report 2017

Publish Date
26-Dec-17
Pages
109
Format
Electronic (PDF)

In this report, the EMEA Liraglutide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Liraglutide for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Liraglutide market competition by top manufacturers/players, with Liraglutide sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    HEC Pharm
    Teva
    Bachem
    Bharat Pharmaceuticals
    Kingpep Biotechnology
    Shenzhen JYMed Technology
    Wuxi Asiapeptide
    AmbioPharm

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Pills
    Liquid

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Drug Store

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Liraglutide Market Report 2017
1 Liraglutide Overview
    1.1 Product Overview and Scope of Liraglutide
    1.2 Classification of Liraglutide
        1.2.1 EMEA Liraglutide Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Liraglutide Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Pills
        1.2.4 Liquid
    1.3 EMEA Liraglutide Market by Application/End Users
        1.3.1 EMEA Liraglutide Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Drug Store
    1.4 EMEA Liraglutide Market by Region
        1.4.1 EMEA Liraglutide Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Liraglutide (2012-2022)
        1.5.1 EMEA Liraglutide Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Liraglutide Revenue and Growth Rate (2012-2022)

2 EMEA Liraglutide Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Liraglutide Market Competition by Players/Manufacturers
        2.1.1 EMEA Liraglutide Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Liraglutide Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Liraglutide Sale Price by Players (2012-2017)
    2.2 EMEA Liraglutide (Volume and Value) by Type/Product Category
        2.2.1 EMEA Liraglutide Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Liraglutide Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Liraglutide Sale Price by Type (2012-2017)
    2.3 EMEA Liraglutide (Volume) by Application
    2.4 EMEA Liraglutide (Volume and Value) by Region
        2.4.1 EMEA Liraglutide Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Liraglutide Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Liraglutide Sales Price by Region (2012-2017)

3 Europe Liraglutide (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Liraglutide Sales and Value (2012-2017)
        3.1.1 Europe Liraglutide Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Liraglutide Revenue and Growth Rate (2012-2017)
    3.2 Europe Liraglutide Sales and Market Share by Type
    3.3 Europe Liraglutide Sales and Market Share by Application
    3.4 Europe Liraglutide Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Liraglutide Sales Volume by Countries (2012-2017)
        3.4.2 Europe Liraglutide Revenue by Countries (2012-2017)
        3.4.3 Germany Liraglutide Sales and Growth Rate (2012-2017)
        3.4.4 France Liraglutide Sales and Growth Rate (2012-2017)
        3.4.5 UK Liraglutide Sales and Growth Rate (2012-2017)
        3.4.6 Russia Liraglutide Sales and Growth Rate (2012-2017)
        3.4.7 Italy Liraglutide Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Liraglutide Sales and Growth Rate (2012-2017)

4 Middle East Liraglutide (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Liraglutide Sales and Value (2012-2017)
        4.1.1 Middle East Liraglutide Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Liraglutide Revenue and Growth Rate (2012-2017)
    4.2 Middle East Liraglutide Sales and Market Share by Type
    4.3 Middle East Liraglutide Sales and Market Share by Application
    4.4 Middle East Liraglutide Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Liraglutide Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Liraglutide Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Liraglutide Sales and Growth Rate (2012-2017)
        4.4.4 Israel Liraglutide Sales and Growth Rate (2012-2017)
        4.4.5 UAE Liraglutide Sales and Growth Rate (2012-2017)
        4.4.6 Iran Liraglutide Sales and Growth Rate (2012-2017)

5 Africa Liraglutide (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Liraglutide Sales and Value (2012-2017)
        5.1.1 Africa Liraglutide Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Liraglutide Revenue and Growth Rate (2012-2017)
    5.2 Africa Liraglutide Sales and Market Share by Type
    5.3 Africa Liraglutide Sales and Market Share by Application
    5.4 Africa Liraglutide Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Liraglutide Sales Volume by Countries (2012-2017)
        5.4.2 Africa Liraglutide Revenue by Countries (2012-2017)
        5.4.3 South Africa Liraglutide Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Liraglutide Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Liraglutide Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Liraglutide Sales and Growth Rate (2012-2017)

6 EMEA Liraglutide Manufacturers/Players Profiles and Sales Data
    6.1 HEC Pharm
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Liraglutide Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 HEC Pharm Liraglutide Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Teva
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Liraglutide Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Teva Liraglutide Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Bachem
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Liraglutide Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Bachem Liraglutide Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Bharat Pharmaceuticals
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Liraglutide Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Bharat Pharmaceuticals Liraglutide Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Kingpep Biotechnology
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Liraglutide Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Kingpep Biotechnology Liraglutide Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Shenzhen JYMed Technology
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Liraglutide Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Shenzhen JYMed Technology Liraglutide Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Wuxi Asiapeptide
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Liraglutide Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Wuxi Asiapeptide Liraglutide Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 AmbioPharm
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Liraglutide Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 AmbioPharm Liraglutide Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview

7 Liraglutide Manufacturing Cost Analysis
    7.1 Liraglutide Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Liraglutide

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Liraglutide Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Liraglutide Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Liraglutide Market Forecast (2017-2022)
    11.1 EMEA Liraglutide Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Liraglutide Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Liraglutide Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Liraglutide Price and Trend Forecast (2017-2022)
    11.2 EMEA Liraglutide Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Liraglutide Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Liraglutide Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Liraglutide Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Liraglutide Sales Forecast by Type (2017-2022)
    11.7 EMEA Liraglutide Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer